The future in multiple myeloma: BiTE immunotherapy, CAR-T, and immune checkpoint inhibitors
Earn CME for related activities: https://www.naccme.com/oln
In this presentation from the Lymphoma & Myeloma 2017, Dr. Adam D. Cohen discusses the future of multiple myeloma therapy, with a specific focus on BITE immunotherapy, CAR-T, and immune checkpoint inhibitors.
© 2017 Imedex, LLC.